Deep Vein Thrombosis
273
22
30
155
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
49 trials with published results (18%)
Research Maturity
155 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.8%
24 terminated out of 273 trials
86.6%
+0.1% vs benchmark
21%
56 trials in Phase 3/4
32%
49 of 155 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 155 completed trials
Clinical Trials (273)
ClotTriever® Thrombectomy System Use-Result Survey in Japan
Personalized Medicine Decision-Making in a Virtual Clinical Setting
Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
Apixaban in Thrombocytopenia
Ancillary Study of the ULTREC Project
Diagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower Limbs
Determining the Validity of ThinkSono Guidance for Ultrasound Image Acquisition and Remote Detection
Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage
PET Fibrin Imaging of DVT and PE
BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis
Weekly Monitoring Strategy of Capillary INR Versus Monthly Monitoring Strategy of Venous INR in Elderly Patients in a Nursing Home.
Comparison Of Percutaneous Mechanical Thrombectomy With Different Access in Treatment of Acute Deep Venous Thrombosis
Leiden Thrombosis Recurrence Risk Prevention
Evaluating the Use of Grip Exercises to Decrease Deep Vein Thrombosis in Adult Patients With PICC Lines
Feasibility of an Early Initiated Physiotherapy Intervention Among Patients With Deep Vein Thrombosis.
Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs
CEFID-I (CEra Flow Improves DVT-1)
CEFID-II (CEra Flow Improves DVT-II)
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients